Global Bacterial Vaginosis Drug Market Research Report 2023

This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs.

The global Bacterial Vaginosis Drug market was valued at US$ 946.3 million in 2022 and is anticipated to reach US$ 1130 million by 2029, witnessing a CAGR of 3.0% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Bacterial Vaginosis Drug key players include Bayer, Pfizer, Sanofi, Piramal, Abbott, etc. Global top five manufacturers hold a share about 20%. North America and Europe is the largest market, both with a share about 30%, followed by China, with a share about 10 percent. In terms of product, OTC is the largest segment, with a share about 70%. And in terms of application, the largest application is Pharmacy, followed by Hospital, etc.

This report aims to provide a comprehensive presentation of the global market for Bacterial Vaginosis Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacterial Vaginosis Drug.

The Bacterial Vaginosis Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Bacterial Vaginosis Drug market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bacterial Vaginosis Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Bacterial Vaginosis Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Rx

1.2.3 OTC

1.3 Market by Application

1.3.1 Global Bacterial Vaginosis Drug Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospital

1.3.3 Pharmacy

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Bacterial Vaginosis Drug Market Perspective (2018-2029)

2.2 Bacterial Vaginosis Drug Growth Trends by Region

2.2.1 Global Bacterial Vaginosis Drug Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Bacterial Vaginosis Drug Historic Market Size by Region (2018-2023)

2.2.3 Bacterial Vaginosis Drug Forecasted Market Size by Region (2024-2029)

2.3 Bacterial Vaginosis Drug Market Dynamics

2.3.1 Bacterial Vaginosis Drug Industry Trends

2.3.2 Bacterial Vaginosis Drug Market Drivers

2.3.3 Bacterial Vaginosis Drug Market Challenges

2.3.4 Bacterial Vaginosis Drug Market Restraints

3.1 Global Top Bacterial Vaginosis Drug Players by Revenue

3.1.1 Global Top Bacterial Vaginosis Drug Players by Revenue (2018-2023)

3.1.2 Global Bacterial Vaginosis Drug Revenue Market Share by Players (2018-2023)

3.2 Global Bacterial Vaginosis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Bacterial Vaginosis Drug Revenue

3.4 Global Bacterial Vaginosis Drug Market Concentration Ratio

3.4.1 Global Bacterial Vaginosis Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Bacterial Vaginosis Drug Revenue in 2022

3.5 Bacterial Vaginosis Drug Key Players Head office and Area Served

3.6 Key Players Bacterial Vaginosis Drug Product Solution and Service

3.7 Date of Enter into Bacterial Vaginosis Drug Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Bacterial Vaginosis Drug Historic Market Size by Type (2018-2023)

4.2 Global Bacterial Vaginosis Drug Forecasted Market Size by Type (2024-2029)

5.1 Global Bacterial Vaginosis Drug Historic Market Size by Application (2018-2023)

5.2 Global Bacterial Vaginosis Drug Forecasted Market Size by Application (2024-2029)

6.1 North America Bacterial Vaginosis Drug Market Size (2018-2029)

6.2 North America Bacterial Vaginosis Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Bacterial Vaginosis Drug Market Size by Country (2018-2023)

6.4 North America Bacterial Vaginosis Drug Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Bacterial Vaginosis Drug Market Size (2018-2029)

7.2 Europe Bacterial Vaginosis Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Bacterial Vaginosis Drug Market Size by Country (2018-2023)

7.4 Europe Bacterial Vaginosis Drug Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Bacterial Vaginosis Drug Market Size (2018-2029)

8.2 Asia-Pacific Bacterial Vaginosis Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Bacterial Vaginosis Drug Market Size by Region (2018-2023)

8.4 Asia-Pacific Bacterial Vaginosis Drug Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Bacterial Vaginosis Drug Market Size (2018-2029)

9.2 Latin America Bacterial Vaginosis Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Bacterial Vaginosis Drug Market Size by Country (2018-2023)

9.4 Latin America Bacterial Vaginosis Drug Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Bacterial Vaginosis Drug Market Size (2018-2029)

10.2 Middle East & Africa Bacterial Vaginosis Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Bacterial Vaginosis Drug Market Size by Country (2018-2023)

10.4 Middle East & Africa Bacterial Vaginosis Drug Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Bayer

11.1.1 Bayer Company Detail

11.1.2 Bayer Business Overview

11.1.3 Bayer Bacterial Vaginosis Drug Introduction

11.1.4 Bayer Revenue in Bacterial Vaginosis Drug Business (2018-2023)

11.1.5 Bayer Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Detail

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Bacterial Vaginosis Drug Introduction

11.2.4 Pfizer Revenue in Bacterial Vaginosis Drug Business (2018-2023)

11.2.5 Pfizer Recent Development

11.3 Sanofi

11.3.1 Sanofi Company Detail

11.3.2 Sanofi Business Overview

11.3.3 Sanofi Bacterial Vaginosis Drug Introduction

11.3.4 Sanofi Revenue in Bacterial Vaginosis Drug Business (2018-2023)

11.3.5 Sanofi Recent Development

11.4 Piramal

11.4.1 Piramal Company Detail

11.4.2 Piramal Business Overview

11.4.3 Piramal Bacterial Vaginosis Drug Introduction

11.4.4 Piramal Revenue in Bacterial Vaginosis Drug Business (2018-2023)

11.4.5 Piramal Recent Development

11.5 Abbott

11.5.1 Abbott Company Detail

11.5.2 Abbott Business Overview

11.5.3 Abbott Bacterial Vaginosis Drug Introduction

11.5.4 Abbott Revenue in Bacterial Vaginosis Drug Business (2018-2023)

11.5.5 Abbott Recent Development

11.6 Galderma

11.6.1 Galderma Company Detail

11.6.2 Galderma Business Overview

11.6.3 Galderma Bacterial Vaginosis Drug Introduction

11.6.4 Galderma Revenue in Bacterial Vaginosis Drug Business (2018-2023)

11.6.5 Galderma Recent Development

11.7 Mission

11.7.1 Mission Company Detail

11.7.2 Mission Business Overview

11.7.3 Mission Bacterial Vaginosis Drug Introduction

11.7.4 Mission Revenue in Bacterial Vaginosis Drug Business (2018-2023)

11.7.5 Mission Recent Development

11.8 Alkem

11.8.1 Alkem Company Detail

11.8.2 Alkem Business Overview

11.8.3 Alkem Bacterial Vaginosis Drug Introduction

11.8.4 Alkem Revenue in Bacterial Vaginosis Drug Business (2018-2023)

11.8.5 Alkem Recent Development

11.9 Xiuzheng

11.9.1 Xiuzheng Company Detail

11.9.2 Xiuzheng Business Overview

11.9.3 Xiuzheng Bacterial Vaginosis Drug Introduction

11.9.4 Xiuzheng Revenue in Bacterial Vaginosis Drug Business (2018-2023)

11.9.5 Xiuzheng Recent Development

11.10 Teva

11.10.1 Teva Company Detail

11.10.2 Teva Business Overview

11.10.3 Teva Bacterial Vaginosis Drug Introduction

11.10.4 Teva Revenue in Bacterial Vaginosis Drug Business (2018-2023)

11.10.5 Teva Recent Development

11.11 Perrigo

11.11.1 Perrigo Company Detail

11.11.2 Perrigo Business Overview

11.11.3 Perrigo Bacterial Vaginosis Drug Introduction

11.11.4 Perrigo Revenue in Bacterial Vaginosis Drug Business (2018-2023)

11.11.5 Perrigo Recent Development

11.12 West-Ward

11.12.1 West-Ward Company Detail

11.12.2 West-Ward Business Overview

11.12.3 West-Ward Bacterial Vaginosis Drug Introduction

11.12.4 West-Ward Revenue in Bacterial Vaginosis Drug Business (2018-2023)

11.12.5 West-Ward Recent Development

11.13 HPGC

11.13.1 HPGC Company Detail

11.13.2 HPGC Business Overview

11.13.3 HPGC Bacterial Vaginosis Drug Introduction

11.13.4 HPGC Revenue in Bacterial Vaginosis Drug Business (2018-2023)

11.13.5 HPGC Recent Development

11.14 Yunnan Baiyao

11.14.1 Yunnan Baiyao Company Detail

11.14.2 Yunnan Baiyao Business Overview

11.14.3 Yunnan Baiyao Bacterial Vaginosis Drug Introduction

11.14.4 Yunnan Baiyao Revenue in Bacterial Vaginosis Drug Business (2018-2023)

11.14.5 Yunnan Baiyao Recent Development

11.15 Starpharma

11.15.1 Starpharma Company Detail

11.15.2 Starpharma Business Overview

11.15.3 Starpharma Bacterial Vaginosis Drug Introduction

11.15.4 Starpharma Revenue in Bacterial Vaginosis Drug Business (2018-2023)

11.15.5 Starpharma Recent Development

11.16 Novel

11.16.1 Novel Company Detail

11.16.2 Novel Business Overview

11.16.3 Novel Bacterial Vaginosis Drug Introduction

11.16.4 Novel Revenue in Bacterial Vaginosis Drug Business (2018-2023)

11.16.5 Novel Recent Development

11.17 Edenvridge

11.17.1 Edenvridge Company Detail

11.17.2 Edenvridge Business Overview

11.17.3 Edenvridge Bacterial Vaginosis Drug Introduction

11.17.4 Edenvridge Revenue in Bacterial Vaginosis Drug Business (2018-2023)

11.17.5 Edenvridge Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Bacterial Vaginosis Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Rx

    Table 3. Key Players of OTC

    Table 4. Global Bacterial Vaginosis Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Bacterial Vaginosis Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Bacterial Vaginosis Drug Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Bacterial Vaginosis Drug Market Share by Region (2018-2023)

    Table 8. Global Bacterial Vaginosis Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Bacterial Vaginosis Drug Market Share by Region (2024-2029)

    Table 10. Bacterial Vaginosis Drug Market Trends

    Table 11. Bacterial Vaginosis Drug Market Drivers

    Table 12. Bacterial Vaginosis Drug Market Challenges

    Table 13. Bacterial Vaginosis Drug Market Restraints

    Table 14. Global Bacterial Vaginosis Drug Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Bacterial Vaginosis Drug Market Share by Players (2018-2023)

    Table 16. Global Top Bacterial Vaginosis Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacterial Vaginosis Drug as of 2022)

    Table 17. Ranking of Global Top Bacterial Vaginosis Drug Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Bacterial Vaginosis Drug Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Bacterial Vaginosis Drug Product Solution and Service

    Table 21. Date of Enter into Bacterial Vaginosis Drug Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Bacterial Vaginosis Drug Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Bacterial Vaginosis Drug Revenue Market Share by Type (2018-2023)

    Table 25. Global Bacterial Vaginosis Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Bacterial Vaginosis Drug Revenue Market Share by Type (2024-2029)

    Table 27. Global Bacterial Vaginosis Drug Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Bacterial Vaginosis Drug Revenue Market Share by Application (2018-2023)

    Table 29. Global Bacterial Vaginosis Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Bacterial Vaginosis Drug Revenue Market Share by Application (2024-2029)

    Table 31. North America Bacterial Vaginosis Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Bacterial Vaginosis Drug Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Bacterial Vaginosis Drug Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Bacterial Vaginosis Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Bacterial Vaginosis Drug Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Bacterial Vaginosis Drug Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Bacterial Vaginosis Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Bacterial Vaginosis Drug Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Bacterial Vaginosis Drug Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Bacterial Vaginosis Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Bacterial Vaginosis Drug Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Bacterial Vaginosis Drug Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Bacterial Vaginosis Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Bacterial Vaginosis Drug Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Bacterial Vaginosis Drug Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Bayer Company Detail

    Table 47. Bayer Business Overview

    Table 48. Bayer Bacterial Vaginosis Drug Product

    Table 49. Bayer Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)

    Table 50. Bayer Recent Development

    Table 51. Pfizer Company Detail

    Table 52. Pfizer Business Overview

    Table 53. Pfizer Bacterial Vaginosis Drug Product

    Table 54. Pfizer Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)

    Table 55. Pfizer Recent Development

    Table 56. Sanofi Company Detail

    Table 57. Sanofi Business Overview

    Table 58. Sanofi Bacterial Vaginosis Drug Product

    Table 59. Sanofi Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)

    Table 60. Sanofi Recent Development

    Table 61. Piramal Company Detail

    Table 62. Piramal Business Overview

    Table 63. Piramal Bacterial Vaginosis Drug Product

    Table 64. Piramal Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)

    Table 65. Piramal Recent Development

    Table 66. Abbott Company Detail

    Table 67. Abbott Business Overview

    Table 68. Abbott Bacterial Vaginosis Drug Product

    Table 69. Abbott Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)

    Table 70. Abbott Recent Development

    Table 71. Galderma Company Detail

    Table 72. Galderma Business Overview

    Table 73. Galderma Bacterial Vaginosis Drug Product

    Table 74. Galderma Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)

    Table 75. Galderma Recent Development

    Table 76. Mission Company Detail

    Table 77. Mission Business Overview

    Table 78. Mission Bacterial Vaginosis Drug Product

    Table 79. Mission Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)

    Table 80. Mission Recent Development

    Table 81. Alkem Company Detail

    Table 82. Alkem Business Overview

    Table 83. Alkem Bacterial Vaginosis Drug Product

    Table 84. Alkem Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)

    Table 85. Alkem Recent Development

    Table 86. Xiuzheng Company Detail

    Table 87. Xiuzheng Business Overview

    Table 88. Xiuzheng Bacterial Vaginosis Drug Product

    Table 89. Xiuzheng Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)

    Table 90. Xiuzheng Recent Development

    Table 91. Teva Company Detail

    Table 92. Teva Business Overview

    Table 93. Teva Bacterial Vaginosis Drug Product

    Table 94. Teva Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)

    Table 95. Teva Recent Development

    Table 96. Perrigo Company Detail

    Table 97. Perrigo Business Overview

    Table 98. Perrigo Bacterial Vaginosis Drug Product

    Table 99. Perrigo Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)

    Table 100. Perrigo Recent Development

    Table 101. West-Ward Company Detail

    Table 102. West-Ward Business Overview

    Table 103. West-Ward Bacterial Vaginosis Drug Product

    Table 104. West-Ward Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)

    Table 105. West-Ward Recent Development

    Table 106. HPGC Company Detail

    Table 107. HPGC Business Overview

    Table 108. HPGC Bacterial Vaginosis Drug Product

    Table 109. HPGC Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)

    Table 110. HPGC Recent Development

    Table 111. Yunnan Baiyao Company Detail

    Table 112. Yunnan Baiyao Business Overview

    Table 113. Yunnan Baiyao Bacterial Vaginosis Drug Product

    Table 114. Yunnan Baiyao Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)

    Table 115. Yunnan Baiyao Recent Development

    Table 116. Starpharma Company Detail

    Table 117. Starpharma Business Overview

    Table 118. Starpharma Bacterial Vaginosis Drug Product

    Table 119. Starpharma Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)

    Table 120. Starpharma Recent Development

    Table 121. Novel Company Detail

    Table 122. Novel Business Overview

    Table 123. Novel Bacterial Vaginosis Drug Product

    Table 124. Novel Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)

    Table 125. Novel Recent Development

    Table 126. Edenvridge Company Detail

    Table 127. Edenvridge Business Overview

    Table 128. Edenvridge Bacterial Vaginosis Drug Product

    Table 129. Edenvridge Revenue in Bacterial Vaginosis Drug Business (2018-2023) & (US$ Million)

    Table 130. Edenvridge Recent Development

    Table 131. Research Programs/Design for This Report

    Table 132. Key Data Information from Secondary Sources

    Table 133. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Bacterial Vaginosis Drug Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Bacterial Vaginosis Drug Market Share by Type: 2022 VS 2029

    Figure 3. Rx Features

    Figure 4. OTC Features

    Figure 5. Global Bacterial Vaginosis Drug Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Bacterial Vaginosis Drug Market Share by Application: 2022 VS 2029

    Figure 7. Hospital Case Studies

    Figure 8. Pharmacy Case Studies

    Figure 9. Other Case Studies

    Figure 10. Bacterial Vaginosis Drug Report Years Considered

    Figure 11. Global Bacterial Vaginosis Drug Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 12. Global Bacterial Vaginosis Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Bacterial Vaginosis Drug Market Share by Region: 2022 VS 2029

    Figure 14. Global Bacterial Vaginosis Drug Market Share by Players in 2022

    Figure 15. Global Top Bacterial Vaginosis Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacterial Vaginosis Drug as of 2022)

    Figure 16. The Top 10 and 5 Players Market Share by Bacterial Vaginosis Drug Revenue in 2022

    Figure 17. North America Bacterial Vaginosis Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 18. North America Bacterial Vaginosis Drug Market Share by Country (2018-2029)

    Figure 19. United States Bacterial Vaginosis Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. Canada Bacterial Vaginosis Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Europe Bacterial Vaginosis Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Bacterial Vaginosis Drug Market Share by Country (2018-2029)

    Figure 23. Germany Bacterial Vaginosis Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. France Bacterial Vaginosis Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. U.K. Bacterial Vaginosis Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Italy Bacterial Vaginosis Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Russia Bacterial Vaginosis Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Nordic Countries Bacterial Vaginosis Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Asia-Pacific Bacterial Vaginosis Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Bacterial Vaginosis Drug Market Share by Region (2018-2029)

    Figure 31. China Bacterial Vaginosis Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Japan Bacterial Vaginosis Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. South Korea Bacterial Vaginosis Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Southeast Asia Bacterial Vaginosis Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. India Bacterial Vaginosis Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Australia Bacterial Vaginosis Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Latin America Bacterial Vaginosis Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Bacterial Vaginosis Drug Market Share by Country (2018-2029)

    Figure 39. Mexico Bacterial Vaginosis Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Brazil Bacterial Vaginosis Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Middle East & Africa Bacterial Vaginosis Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Bacterial Vaginosis Drug Market Share by Country (2018-2029)

    Figure 43. Turkey Bacterial Vaginosis Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Saudi Arabia Bacterial Vaginosis Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Bayer Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)

    Figure 46. Pfizer Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)

    Figure 47. Sanofi Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)

    Figure 48. Piramal Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)

    Figure 49. Abbott Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)

    Figure 50. Galderma Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)

    Figure 51. Mission Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)

    Figure 52. Alkem Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)

    Figure 53. Xiuzheng Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)

    Figure 54. Teva Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)

    Figure 55. Perrigo Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)

    Figure 56. West-Ward Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)

    Figure 57. HPGC Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)

    Figure 58. Yunnan Baiyao Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)

    Figure 59. Starpharma Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)

    Figure 60. Novel Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)

    Figure 61. Edenvridge Revenue Growth Rate in Bacterial Vaginosis Drug Business (2018-2023)

    Figure 62. Bottom-up and Top-down Approaches for This Report

    Figure 63. Data Triangulation

    Figure 64. Key Executives Interviewed